Procter & Gamble Articles

Selecting Diseases Suitable For OTC Treatment

4 December 1998

Procter & Gamble plans to file Stedicor

26 November 1998

Optimism Over URT OTCs In Europe

24 November 1998

Risedronate Cuts Fractures In Steroid-Using Patients

12 November 1998

Germany's IDEA Signs Deal With P&G

2 November 1998

First Launch Of Actonel For Paget's

21 October 1998

First Oral Periodontitis Treatment In USA

8 October 1998

Stock Commentary New York

6 August 1998

Merck, Pfizer Lead Charge Up Global Rankings

7 July 1998

Hoechst Confirms Life Science Focus

5 May 1998

Risedronate Cleared By FDA For Paget's

8 April 1998

Bad Times Soon Over, Says Hoechst Marion Roussel

12 March 1998

Risedronate In Osteoporosis Prevention

5 March 1998

FDA Clears GW's Effervescent Zantac

5 March 1998

P&G Finalizes Deal With Astra Merck

13 January 1998

Astra Merck And P&G To Market OTC Prilosec

18 December 1997

NDMA Meeting Discusses OTC Drug Labeling

5 December 1997

P&G And TheraTech: Testosterone Patches For Women

4 December 1997

Azimilide To Be Tested In Phase III Study

20 November 1997

P&G Licenses Azimilide To Tanabe

23 October 1997

US Industry Urged To Back MRAs With EU

3 October 1997

P&G To File NDA For Actonel In 1998

17 September 1997

Gene Logic Enters Genomics Alliance With JT

11 September 1997

P&G's Asacol Cleared In USA

28 August 1997

P&G and Regeneron Deal "Now Effective"

19 June 1997

P&G Signs Deal With Gene Logic

19 June 1997

UK Clears Didronel PMO For Prevention

9 June 1997

Alora Launched In USA

30 May 1997

P&G/Regeneron In $135m Deal

19 May 1997

FDA OTC Label Change Proposal Discussed

12 May 1997

Hoechst Warns Of A Tough Year Of Changes

12 May 1997

Fast Growth For Euro Cough/Cold OTCs

24 February 1997

US H2 Blocker Boom Forecast To Slow Down

27 January 1997

Fast Growth In Russian OTC Market

20 January 1997

Acquisitions And Mergers Continue, Led By Novartis

6 January 1997

P&G And Regeneron In Muscle Disease Collaboration

23 December 1996

New Over-The-Counter League From IMS

23 December 1996

Glaxo Granted Rights To P&G Ulcer Drug

2 December 1996

EUROPEAN AND LONDON STOCK COMMENTS

2 December 1996

NDMA On DTC Ads And Post-Marketing Research

2 December 1996

H2 Blockers' US Sales Boom Set To Slow?

21 October 1996

Roche And Bayer Link Up In US OTC Joint Venture

23 September 1996

P&G To Launch Low-Cost Helicobacter Regimen In USA

2 September 1996

Lilly Signs $100 Million Antibiotic Deal With Dura

2 September 1996

Drugmakers Et Al Accused Of Anti-FDA Campaigning

12 August 1996

Single-Digit Profits Growth For B-MS And W-L

5 August 1996

Further Applications Filed For Alora Patch

8 July 1996

Roche Moves To Increase OTC Stake In USA

8 July 1996

Sales In Line With Expectations At Roche In '96 1st Qtr

22 April 1996

Germany Approves P&G's Didronel

15 April 1996

P&G Expands Pharma Business In Brazil

8 April 1996

Tylenol/Advil Ad Row "A US Investment Non-Event"

1 April 1996

Health Care Appointment At P&G

25 March 1996

European OTC Market Growth To 2006

5 February 1996

Alpharma gets generics approval

15 January 1996

Ulcer Therapy Market Set For Transformation

18 December 1995

Sandoz Launches Nasal Calcitonin In USA

18 December 1995

TheraTech/Solvay Collaborate On New HRT

6 November 1995

Procter & Gamble : Norwegian Didronate approval

6 November 1995

Procter & Gamble's Didronel: new study data

25 September 1995

Sandoz' Calcitonin Spray Approved

11 September 1995

Results US Biopharmaceutical Firms Progress In Second Quarter

4 September 1995

Procter & Gamble /Forest Lorcet deal

21 August 1995

P & G NDA for bismuth....

7 August 1995

Canada Approves Procter & Gamble's Didrocal

31 July 1995

Merck's Fosamax Nears Market In USA

24 July 1995

US Sales of Generic Drugs Up 29% In 1994, Says IMS

17 July 1995

Global Self-Med Market Now 18% Of Total Pharma Sector

17 July 1995

Good Performance Forecast For Euro Drugmakers

26 June 1995

Merck's Fosamax Set For Rapid US Approval?

12 June 1995

The ABPI's A-Z Of British Medicines Research

29 May 1995

Are OTC Makers Targeting The Right markets?

8 May 1995

Grelan To Distribute TheraTech Patch

24 April 1995

Procter & Gamble Investment In Brazil

20 March 1995

Didronate Approval In Sweden

6 March 1995

Analysts' Eyes On Warner-Lambert

20 February 1995

Proctewr & Gamble Deal

6 February 1995

Panel Dismisses Etidronate Osteoporosis Claim

28 November 1994

NDMA Discusses Switch Changes At Legal Seminar

14 November 1994

Role of Legal Counsel In US Rx-to-OTC Switching

7 November 1994

Didrocal To Be Reviewed By FDA

31 October 1994

Successful Rx-To-OTC Drug Switching: NDMA

31 October 1994

SmithKline Beecham To Acquire Sterling Winthrop

5 September 1994

Aleve, Advil Dispute Blows Up

22 August 1994

PROCTER & GAMBLE SEEK INJUNCTION IN JAPAN

15 August 1994

WHAT FUTURE FOR STERLING HEALTH

4 July 1994

THE CHANGING US ANALGESIA MARKET

27 June 1994

PROCTER & GAMBLE RESULTS AFFECTED BY INTEREST SWAP

20 June 1994

PROCTER & GAMBLE TO TO CLOSE PLANTS

20 June 1994

ZIAC HYPOTENSION LAUNCHED IN USA

23 May 1994

CELSIS EXECUTIVE WAS "INEFFECTUAL"

18 April 1994

PROCTER & GAMBLE PARTNERSHIP

11 April 1994

ACTISITE CLEARED FOR MARKET IN USA

11 April 1994

TILUDRONATE EFFICACY SHOWN

4 April 1994

GENERIC COMPETITION HITS SYNTEX

7 March 1994

GENEVA PHARMA AGREEMENT

14 February 1994

RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK

14 February 1994

FIRST OTC NAPROXEN CLEARED FOR SALE

17 January 1994

EXPANDING PHARMA MARKET IN TURKEY

10 January 1994

MUSCULOSKELETAL MARKET TO DECLINE

6 December 1993

Showing 201-300 of 334 articles

Go to beginningPreviousNextGo to end